Chronic subdural haematoma is one of the most common conditions in general neurosurgical practice. Its incidence in the general population is about 5 per 100,000 per year, with increasing incidence linked to age. It presents with a wide variety of symptoms and accounts for approximately 1% of all hospital admissions with acute confusion. This chapter explores the management of chronic subdural haematoma through a case study. As more patients survive into their ninth and tenth decades, not only will the incidence of CSDH continue to rise, but surgeons will be faced with increasingly complex patients with multiple medical co-morbidities. In particular, the issue of anticoagulation is likely to become more pertinent. Further research should be directed towards establishing evidence-based guidelines for resuming anticoagulation and antiplatelet medication after CSDH surgery. By identifying risk factors for both recurrence and thromboembolism, the decision can then be taken on a case-by-case basis, tailored to the individual’s risk factors.
